Cargando…
Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data
Introduction. Patient-level simulation models facilitate extrapolation of clinical trial data while allowing for heterogeneity, prior history, and nonlinearity. However, combining different types of uncertainty around within-trial and extrapolated results remains challenging. Methods. We tested 4 me...
Autores principales: | Dakin, Helen A., Leal, José, Briggs, Andrew, Clarke, Philip, Holman, Rury R., Gray, Alastair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323001/ https://www.ncbi.nlm.nih.gov/pubmed/32431211 http://dx.doi.org/10.1177/0272989X20916442 |
Ejemplares similares
-
Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning
por: Dakin, Helen A., et al.
Publicado: (2020) -
Temporal Validation of the UKPDS Outcomes Model Using 10-Year Posttrial Monitoring Data
por: Leal, Jose, et al.
Publicado: (2013) -
Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial
por: Becker, Frauke, et al.
Publicado: (2022) -
Uncertainties in interspecies extrapolations of carcinogenicity.
por: Crouch, E A
Publicado: (1983) -
Which interactions matter in economic evaluations? A systematic review and simulation study
por: Dakin, Helen, et al.
Publicado: (2020)